XM does not provide services to residents of the United States of America.

UK's Halma shares soar after dividend hike and profit jump



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>UPDATE 2-UK's Halma shares soar after dividend hike and profit jump</title></head><body>

FY adj pre-tax profit up 10% to 396.4 mln stg

Forecasts growth in FY organic revenue

Shares up 11.9%

Updates shares, adds CFO comment in paragraphs 6-7 and details throughout

By DhanushVignesh Babu

June 13 (Reuters) -British health and safety device maker Halma HLMA.L on Thursday raised its dividend for the 45th consecutive year after posting a 10% jump in annual profit driven by acquisitions and strong demand across its products and services.

Shares in Halma jumped 11.9% to 26.3 pounds by 12:36 GMT, their highest level in more than two years, after the company also forecast organic revenue would grow this fiscal year.

Halma, which operates in over 20 countries across safety, healthcare and environmental & analysis, reported annual revenue growth of 9.8% to 2.03 billion pounds, crossing the 2 billion pound mark for the first time.

"We have made a positive start to the new financial year. Our order intake in the year to date is ahead of both revenue and the comparable period last year," CEO Marc Ronchetti said in a statement.

Despite sturdy growth in its other two divisions, the healthcare unit, which provides healthcare assessment and analytics, saw a weak performance.

"The challenges we are receiving in healthcare sector is global. We saw a significant amount of OEM (original equipment manufacturer) destocking of last 12 or 18 months and a number of budgetary pressures on the healthcare system," CFO Steve Gunning said in a call with Reuters.

The company invested over 200 million pounds in the healthcare sector, including M&A, this year, Gunning added.

"Total acquisition spend was down after record spending the prior year. While there’s no point in spending for the sake of it, investors will be hoping to see a little more activity over 2024," Hargreaves Lansdown analyst Matt Britzman said.

Halma has invested 689 million pounds in acquisitions over the last two financial years.

The Buckinghamshire-headquartered company logged an adjusted profit before tax of 396.4 million pounds ($506.60 million) for the year ended March 31, 2% ahead of consensus and the 361.3 million pounds a year earlier.

($1 = 0.7825 pounds)



Reporting by DhanushVignesh Babu in Bengaluru; Editing by Mrigank Dhaniwala and Christina Fincher

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.